Metal–Organic Framework as a Bioorthogonal Catalyst for Gene Editing
Journal of the American Chemical Society · 19.08.2026 · 148 (32) · 34114-34127
DOI: 10.1021/jacs.6c03260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 24.06.2026. Verfasst von Ziyi Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan430072, China. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Gene Editing. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China (NSFC), National Basic Research Program of China (973 Program).
Abstract (Originalsprache)
We report the use of reticular design to construct metal–organic frameworks (MOFs) with molecularly defined catalytic pores for bioorthogonal RNA manipulation in living cells. A library of crystalline MOFs with systematically varied Cu cluster geometries, pore dimensions, and chemical environments was assembled to interrogate how structural precision influences RNA recognition and conversion within confined spaces. By integration of redox-stable Cu(I) clusters with dimensionally matched mesopores, selected MOFs were capable of catalyzing efficient and quantitative RNA bond cleavage and formation reactions in living systems without external reducing agents. Small-angle X-ray scattering reveals that pore chemistry governs substrate positioning relative to catalytic centers, enabling preferential engagement of protected RNA and facilitated release of original RNA as products, thereby driving complete conversion. Synchrotron soft X-ray microscopy was used to visualize intracellular localization and integrity of MOF in cells, further validating MOF as a bioorthogonal catalyst. An amine-functionalized framework, MOF-248-NH2, enabled controlled sgRNA activation for CRISPR/Cas9 gene editing regulation in cells and treatment of cardiac disease in a canine model. These results establish reticular pore engineering as a powerful strategy to make MOFs programmable bioorthogonal catalysts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers Ministry of Education, College of Chemistry and Molecular Sciences, Wuhan University, Wuhan430072, China.
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan430072, China.
- School of Physical Science and Technology, ShanghaiTech University, Shanghai201210, China.
- The Institute for Advanced Studies, Wuhan University, Wuhan430072, China.
ORCID-Profile: Ziyi Chen, Gaoli Hu, Enci Zhang, Lilei Yu, Huaidong Jiang, Tian Tian, Xiang Zhou, Hexiang Deng
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China (NSFC)
- National Basic Research Program of China (973 Program)
Zitieren
APA
Chen, Z., Liu, X., Sang, W., Li, L., Xiao, J., Hu, G., Zhou, L., Qi, Q., Peng, C., Huang, J., Xiong, W., Li, Z., Chen, N., Zhang, E., Yu, L., Jiang, H., Tian, T., Zhou, X., & Deng, H. (2026). Metal–Organic Framework as a Bioorthogonal Catalyst for Gene Editing. Journal of the American Chemical Society, 148(32), 34114-34127. https://doi.org/10.1021/jacs.6c03260
Vancouver
Chen Z, Liu X, Sang W, Li L, Xiao J, Hu G, et al. Metal–Organic Framework as a Bioorthogonal Catalyst for Gene Editing. Journal of the American Chemical Society. 2026;148(32):34114-34127. doi:10.1021/jacs.6c03260
BibTeX
@article{Chen2026,
author = {Chen, Ziyi and Liu, Xingyu and Sang, Wanyue and Li, Lei and Xiao, Jingcheng and Hu, Gaoli and Zhou, Liping and Qi, Qianqian and Peng, Chen and Huang, Jiaxing and Xiong, Wei and Li, Zikun and Chen, Nuo and Zhang, Enci and Yu, Lilei and Jiang, Huaidong and Tian, Tian and Zhou, Xiang and Deng, Hexiang},
title = {Metal–Organic Framework as a Bioorthogonal Catalyst for Gene Editing},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {32},
pages = {34114--34127},
doi = {10.1021/jacs.6c03260}
}
EUVIMED